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Iron is essential for growth of Mycobacterium tuberculosis (Mtb), but most iron in the human
body is stored in heme within hemoglobin. Here, we demonstrate that the substrate-binding
protein DppA of the inner membrane Dpp transporter is required for heme and hemoglobin
utilization by Mtb. The 1.27 Å crystal structure of DppA shows a tetrapeptide bound in the
protein core and a large solvent-exposed crevice for heme binding. Mutation of arginine 179
in this cleft eliminates heme binding to DppA and prevents heme utilization by Mtb. The
outer membrane proteins PPE36 and PPE62 are also required for heme and hemoglobin
utilization, indicating that these pathways converge at the cell surface of Mtb. Albumin, the
most abundant blood protein, binds heme speciﬁcally and bypasses the requirements for
PPE36, PPE62 and Dpp. Thus, our study reveals albumin-dependent and -independent heme
uptake pathways, highlighting the importance of iron acquisition from heme for Mtb.
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I

ron, due to its versatile coordination properties and tunable
redox state, is used in many essential biological processes1. An
important part of the innate immune response to bacterial
infections is the limitation of accessible iron in the human host
which is sequestered in high-afﬁnity binding proteins such as
transferrin, ferritin, and lactoferrin or in heme2. Hence, for many
bacterial pathogens, iron is the limiting factor for colonization
and infection3. A large body of evidence links iron availability to
tuberculosis (TB) pathogenesis4. For example, iron overload was
found to increase the risk of TB, of TB treatment failure, and of
mortality in TB patients. Human genetic disorders or gene variations such as haptoglobin and NRAMP1 polymorphisms
increased iron levels in macrophages and the risk of TB and/or
worsen disease outcomes. It was concluded that the host’s iron
status is an important yet under-evaluated factor in TB prevention and therapy4.
Recently, Rodriguez and co-workers5 showed that the necrotic
centers of granulomas of human TB patients contain a high
concentration of host iron-sequestering proteins and ironrestricting factors, likely establishing an iron-deprived environment for M. tuberculosis (Mtb). These results not only highlighted
strict iron restriction at the primary sites of Mtb infection in
humans but, unexpectedly, also revealed that prolonged iron
starvation triggers a transition of Mtb to a persistent state, a
hallmark of chronic TB5. To counteract the iron limitation in the
host, Mtb secretes siderophores, small molecules with extremely
high iron-binding afﬁnities, called (carboxy)mycobactins6–8. Mtb
can also directly utilize heme and hemoglobin as iron sources9,10.
The importance of these iron acquisition mechanisms for virulence of Mtb was shown in several reports. For example, the ATPbinding cassette (ABC) transporter IrtAB is required for efﬁcient
utilization of iron from ferric carboxymycobactin and for replication of Mtb in macrophages and mice11. A mutant of Mtb
lacking ferritin, an iron storage protein, is unable to establish a
chronic infection in mice12 and IdeR, the main regulator of iron
homeostasis in Mtb, is required for virulence in Mtb13.
It is estimated that more than 70% of iron in the human body
is tightly bound in heme and complexed with hemoglobin making
heme the major iron source in the human host14. In diderm
bacteria host hemoproteins or heme are captured by outer
membrane receptors to transport heme into the periplasm. Heme
is then transported across the inner membrane by permeases,
which are speciﬁc ABC importers14. Recently, we identiﬁed
PPE36 and PPE62 as membrane-anchored, heme-binding proteins on the cell surface of Mtb that are required for heme utilization15. PPE36 and PPE62 do not share any sequence similarity
with known heme-binding proteins16. MmpL3 and MmpL11
were proposed as the inner membrane importers of heme in
Mtb10. However, MmpL3 and MmpL11 are RND-type efﬂux
pumps involved in export of trehalose monomycolate, lipids, or
other lipid-like molecules for maintenance of the mycobacterial
cell wall17–19. Thus, the roles of MmpL3 and MmpL11 in heme
utilization by Mtb are unclear15.
Herein, we show that heme and hemoglobin utilization converge at the cell surface of Mtb after heme is released from
hemoglobin and demonstrate that the substrate-binding protein
DppA is required for heme uptake across the inner membrane of
Mtb. We also show that Mtb is capable of utilizing heme in the
presence of albumin bypassing the requirement of PPE and DppA
proteins.
Results
The Dpp transporter is essential for heme utilization by Mtb.
To identify potential inner membrane heme uptake systems, we
searched for Mtb proteins with similarities to bacterial heme
2

transporters. While Mtb does not have any homologs of the heme
permease HemTUV14,20 (Supplementary Table 1), the Mtb
rv3666c-rv3663c operon encodes four proteins that share
~24–45% sequence similarities with the dipeptide transporter
Dpp of Escherichia coli, which also enables heme uptake21. The
components of the Mtb Dpp transporter include DppA (R3666c;
substrate-binding protein), DppB/C (R3665c/Rv3664c, integral
membrane permease proteins), and DppD (Rv3663c, ATPase).
To examine whether the Mtb Dpp transporter is involved in
heme utilization, we deleted the entire dpp operon in the avirulent
Mtb strain mc26206 by homologous recombination as previously
described15. The Mtb Δdpp mutant was named ML2436 (Supplementary Fig. 1B, C; Supplementary Table 2). Deletion of the
dpp operon did not affect the growth of Mtb in HdB minimal
medium with 10 µM ammonium ferric citrate as the sole iron
source (Fig. 1a), but completely abolished growth with 10 µM
hemin and 2.5 µM human hemoglobin (Fig. 1b). The initial
residual growth of the Mtb Δdpp mutant is probably due to
incomplete depletion of the internal iron storage12,22. The dpp
operon expression vector pML3757 (Supplementary Table 3)
restored the ability of the Δdpp mutant to utilize hemin and
hemoglobin demonstrating that the growth defect of Mtb
ML2436 was indeed caused by the lack of the dpp operon (Fig. 1b,
Supplementary Fig. 2). These results show that the Dpp transporter is essential under these growth conditions for both heme
and hemoglobin utilization in Mtb.
The Mtb genes rv1283c-rv1280c, annotated as opp genes,
encode proteins that share sequence similarities with bacterial
oligopeptide and dipeptide transporters23. However, the rv1283crv1280c operon expression plasmid pML3758 (Supplementary
Table 3) did not restore heme utilization in the Δdpp mutant
ML2436 in contrast to the dpp operon expression vector
(Supplementary Fig. 2). This result is consistent with the severe
growth defect of the Mtb Δdpp mutant, despite the presence of a
functional opp operon, in medium with heme as the only iron
source (Fig. 1b). Collectively, these results show that the Dpp
transporter is the major heme transporter in the inner membrane
of Mtb.
PPE proteins are required for heme and hemoglobin utilization by Mtb. Previously, we identiﬁed PPE36 and PPE62 as
membrane-anchored cell surface-accessible proteins which bind
heme and are required for efﬁcient heme utilization of Mtb15.
Here, we sought to examine whether PPE36 and PPE62 also play
a role in hemoglobin utilization by Mtb. The Δppe36 mutant
ML2411 did not grow in HdB minimal medium with human
hemoglobin or with heme as the sole iron source (Fig. 1c)
demonstrating that PPE36 is essential for both heme and
hemoglobin utilization by Mtb under these growth conditions.
Growth of the Δppe62 mutant ML2412 with heme and hemoglobin was also impaired (Fig. 1d) demonstrating that PPE62
plays an important role both in heme and hemoglobin utilization.
This result also indicated that PPE62 has a functional homolog in
Mtb, which accounts for the residual growth of the Δppe62
mutant.
A recent study showed that PPE37 (Rv2123) is essential for
heme utilization in the Mtb Erdman strain and that deletion of
ppe36 had no effect24. This was puzzling considering that the
ppe36 gene is essential for both heme and hemoglobin utilization
in the avirulent Mtb strain mc26206 (Fig. 1c) consistent with our
previous results15. Mtb mc26206 (H37Rv ΔpanCD ΔleuCD) is an
isogenic, avirulent Mtb strain25 derived from Mtb H37Rv, a
laboratory Mtb strain commonly used in research. To address this
discrepancy, we deleted the ppe37 gene in Mtb mc26206
(Supplementary Fig. 3B, Supplementary Table 2). Growth of the
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Fig. 1 Heme and hemoglobin utilization by M. tuberculosis and mutant strains. Growth of the avirulent Mtb strain mc26206 (wt; circles), the Δdpp mutant
ML2436 (triangles), and the complemented Δdpp mutant (squares) in HdB minimal medium with a 10 µM ammonium ferric citrate and b 2.5 µM human
hemoglobin (cyan) or 10 µM hemin (blue). Growth of Mtb mc26206 (circles), the Δppe36 mutant ML2411 (triangles) (c), and the Δppe62 mutant ML2412
(triangles) (d) in HdB minimal medium with 2.5 µM hemoglobin (cyan) or 10 µM hemin (blue). Medium with hemin and hemoglobin contained 20 µM of
2,2′-dipyridyl to prevent utilization of trace ferric iron. Error bars represent standard errors of mean values of biological triplicates. Source data are provided
in the Source Data ﬁle

Δppe37 mutant in HdB minimal medium in the presence of
10 µM hemin or 2.5 µM human hemoglobin was identical to that
of the parent strain conﬁrming that PPE37 is not required for
growth on heme in Mtb mc26206 (Fig. 2a). It should be noted
that we did not examine whether PPE37 is required for heme
utilization in Mtb H37Rv.

(Fig. 3b). The iron starvation of the Δdpp mutant in HdB medium
with heme as the sole iron source and its increased resistance to
the toxicity of heme strongly indicate that the Dpp transporter of
Mtb is involved in heme uptake and not in heme efﬂux. This
conclusion is consistent with the function of the Dpp systems in
other bacteria14,21,29.

Directionality of heme transport by the Dpp system. Many
heme-utilizing bacteria have ABC transporter efﬂux systems for
heme detoxiﬁcation26,27. To examine whether the Dpp transporter is involved in heme uptake or efﬂux, we monitored the
growth of wt Mtb, the Δdpp mutant and the complemented strain
in HdB minimal medium containing 1 µM ferric citrate and
increasing concentrations of hemin. Hemin was toxic for wt Mtb
with an IC50 of ~135 µM (Fig. 3a). Deletion of the dpp genes
increased the toxic concentration of hemin to an IC50 of
~200 µM. The susceptibility of the Δdpp mutant to hemin was
fully restored to wt levels by expression of the dpp operon
(Fig. 3a). The increased resistance of the Δdpp mutant to heme
toxicity strongly suggests that the Dpp transporter is not involved
in heme efﬂux but rather in heme uptake. In an alternative
approach to examine whether the Dpp transporter is involved in
heme uptake, we determined transcription levels of six mycobactin biosynthesis genes (mbt) from two mbt loci representing
three operons28 as an indicator of iron availability7. The mRNA
levels of all six selected mbt genes as determined by quantitative
real-time PCR were increased by more than two-fold in the Δdpp
mutant compared to wt Mtb when the strains were grown in
minimal medium with hemin as the sole iron source (Fig. 3b).
Expression of the dpp operon reduced transcription of the mbt
genes to wt levels demonstrating that the iron starvation of the
Δdpp mutant was indeed due to the lack of the dpp operon

Cell permeability of Mtb Δdpp to hydrophobic compounds. It
was previously reported that deletion of the rv3665c-rv3663c
genes in a clinical Mtb strain alters levels of the outer membrane
lipids phthiocerol dimycocerosates (PDIMs) and mycolic acids23.
Since heme is a hydrophobic molecule, it is possible that deletion
of the dpp operon could alter the outer membrane lipid composition and enhance its function as a permeability barrier,
thereby reducing heme uptake. To examine the cell permeability
of the Δdpp mutant, we measured the uptake of ethidium bromide as a hydrophobic compound whose uptake is detectable by
ﬂuorescence30. The uptake rates for ethidium bromide by wt Mtb
and the Δdpp mutant were identical (Supplementary Fig. 4),
indicating that the heme uptake defect in the Δdpp mutant is not
due to altered cell permeability.
Role of peptides in heme uptake by Mtb. Previous studies
showed that Dpp-dependent heme utilization in E. coli is inhibited by peptides21. Deletion of dpp genes in a clinical Mtb isolate
conferred resistance to the toxic tripeptide bialaphos suggesting
that the Mtb Dpp transporter is also involved in peptide transport23. To examine whether peptides interfere with heme uptake,
we examined the growth of Mtb in HdB minimal medium with
ammonium ferric citrate, hemin, or human hemoglobin as iron
sources in the presence of peptides. While 1% tryptone, a tryptic
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Fig. 2 Characterization of the M. tuberculosis Δppe37 mutant. a Growth of avirulent Mtb strain mc26206 (wt; circles) and Δppe37 mutant (triangles) in HdB
minimal medium with 10 µM hemin (red) or 2.5 µM human hemoglobin (blue). b Growth of avirulent Mtb strain mc26206 (wt; black circles) and Δppe37
(red triangles) in HdB minimal medium with 0.5% bovine serum albumin and 10 µM hemin. All media contained 20 µM of 2,2′-dipyridyl to prevent
utilization of trace iron. Error bars represent standard errors of mean values of biological triplicates. Source data are provided in the Source Data ﬁle

a

b

140

50

wt

100

Δdpp

80
60
40

IC50

20

+dpp

mRNA [a.u.]

Growth [%]

120

40

50
10
0
15
0
20
0
25
0
30
0

.5
25

12

0
25
6.

mbtJ
mbtC
mbtM

30
20
10
0

0

mbtA
mbtB
mbtL

WT

Δdpp

+dpp

Hemin [μM]

Fig. 3 The M. tuberculosis Δdpp mutant is resistant to heme toxicity and experiences iron starvation. a Growth of wt Mtb (circles), the Δdpp mutant
(triangles), and the complemented Δdpp mutant (squares) in HdB minimal medium with 1 µM ammonium ferric citrate and increasing concentrations of
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digest of the milk protein casein, did not affect growth of Mtb in
medium with ammonium ferric citrate, growth with heme or
hemoglobin was reduced (Supplementary Fig. 5). Expression of
the dpp operon (pML3757; Supplementary Table 3) increased
growth of Mtb with heme and hemoglobin as iron sources in the
presence of tryptone-derived peptides (Supplementary Fig. 5).
Collectively, these results indicate that peptides can interfere with
heme uptake by the Mtb Dpp transporter.
DppA is a heme-binding protein of Mtb. Bacterial DppA proteins are periplasmic proteins with a classical Sec signal peptide
that have been implicated in heme binding21. To examine whether DppA of Mtb (Rv3666c) binds heme, we constructed an
expression vector for E. coli encoding DppAMtb lacking the predicted signal peptide and produced milligram quantities of
apparently pure recombinant DppAMtb (Fig. 4a). Addition of
hemin to DppAMtb in surface plasmon resonance experiments
resulted in a dose-dependent increase in signal intensity indicative of heme binding (Fig. 4b). The dissociation constant Kd was
calculated to be ~1.5 µM. Thus, the heme afﬁnity for DppAMtb is
higher than that of other DppA proteins with dissociation constants ranging from ~10 µM for DppAEc to ~655 µM for the
DppA homolog HbpA of Haemophilus inﬂuenzae (Supplementary Table 4). We also examined heme binding of DppAMtb by
difference absorption spectroscopy. Subtracting the free heme
spectra from the heme-protein spectra resulted in a characteristic
Soret peak at ~410 nm and a broad Q band beak at ~550 nm
4

(Fig. 6b, see below) which are indicative of heme binding by
DppAMtb in solution. These results demonstrate that DppAMtb is
a heme-binding protein.
High-resolution crystal structure of Mtb DppA. We obtained
high-quality crystals of Mtb DppA that were used to determine a
3D-structure of the protein at 1.27 Å resolution. The atomic
model of DppA, reﬁned to an Rwork/free of 12.8/16.5% (Table 1),
sheds light on the molecular architecture of this periplasmic heme
carrier with high accuracy. Mtb DppA has a globular shape that
resembles a heart (Fig. 4c). Despite the compact appearance, the
DppA tertiary structure is built by two globular and slightly offset
halves that fold onto each other with perfect complementarity like
the shells of a clam. The N-terminal half of the molecule (residues
1–249) connects to the C-terminal half (residues 267–541) by a
ﬂexible α-helical hinge (residues 250–266) that has higher than
average B-factor in our structure (28.0 vs. 18.6 Å2). This hinge
resembles a “clothespin spring” that keeps the two halves of
DppA in a closed conformation poised to open up (Fig. 4d). Mtb
DppA is similar to the homologous proteins found in Gramnegative bacteria, especially to the Salmonella typhimurium
ortholog that superimposes to Mtb DppA with an RMSD ~1.45
Å. At the interface between the two DppA halves, completely
buried inside the protein core, is a tetrapeptide whose amino acid
sequence was modeled as Ser-Ser-Val-Thr (Fig. 4e). The electron
density for this peptide is well-resolved, consistent with a tight
binding. Accordingly, all attempts to remove the tetrapeptide
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from DppA by dialysis against 1 M urea followed by recrystallization failed.
Identiﬁcation of a potential heme-binding site by modeling. To
visualize how DppA binds heme, we formed a complex of DppA
with heme in solution and puriﬁed the complex by size exclusion
chromatography (Supplementary Fig. 6A). The presence of the
DppA–heme complex was indicated by the reddish-color of
DppA-containing fractions (Supplementary Fig. 6B, C). Absorption spectroscopy of the pooled fractions revealed a strong Soret
peak at 405 nm characteristic for heme-bound proteins (Supplementary Fig. 6D). We obtained at least three morphologically
different crystals of the puriﬁed DppA–heme complex in buffers
of high and low ionic strengths and pH values ranging from pH
4.5 to 8 and determined their atomic structures. All crystals
shared an identical primitive monoclinic cell with only 34% solvent content (Table 1). Surprisingly, none of these crystallized
DppA proteins were bound by heme. We hypothesized that the
effect of dehydrating agents used for crystallization and crystal

lattice forces stabilize a closed conformation of DppA incompatible with heme binding. To test this hypothesis, we scanned the
DppA surface for solvent-accessible pockets that could be ﬁlled by
heme and expose at least one histidine, the major iron-binding
residue in proteins14. The CASTp software31 identiﬁed a solventaccessible pocket at the interface generated by N- and C-terminal
halves with a Richards’ solvent-accessible volume of ~268 Å3
(Fig. 5a). This cleft contains several putative heme-binding residues, including His131 and Arg179, and is ﬁlled with solvent in
our structure. However, it is too small to accommodate heme, as
also suggested by in silico docking experiments that failed to yield
a convincing solution of a DppA–heme complex. To explore the
DppA conformational ﬂexibility and identify alternative conformations of the protein compatible with heme binding, the 1.27
Å crystallographic model of DppAMtb was subjected to normal
mode analysis. It is well established that low-frequency modes can
be useful to describe large-scale motions of proteins32. Out of the
ﬁve lowest frequency modes of DppA, the ﬁrst three produced a
wide opening of the cleft caused by a concerted motion of the two
halves that open like a clamp by 10.7 Å, slightly twisting in
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Table 1 Crystallographic data collection and reﬁnement
statistics

Data collection
Space group
Cell dimensions
a, b, c (Å)
α, β, γ (°)
Resolution (Å)
Rsym
I/σI
Completeness (%)
Redundancy
Reﬁnement
Resolution (Å)
No. of reﬂections
Rwork/Rfreea
No. of atoms
Protein
Water
B-factors
Protein
Water
R.m.s. deviations
Bond lengths (Å)
Bond angles (°)
aValues

DppAwt

DppAR179A

P21

P21

52.7, 69.1, 62.4
90.0, 106.5, 90.0
50–1.27 (1.32–1.27)a
6.6 (50.7)
37.8 (2.3)
91.1 (51.3)
6.1 (3.2)

52.6, 68.9, 62.1
90.0, 103.3, 90.0
15–1.25 (1.29–1.25)a
8.9 (72.3)
30.4 (2.2)
98.7 (89.6)
4.2 (3.4)

50–1.27
98,354
12.8/16.5

15–1.25
114,872
16.8/18.8

4389
590

4402
619

21.7
30.4

19.5
27.3

0.009
1.441

0.005
0.789

Role of tetrapeptide binding in the core of DppA. To examine
the effect of tetrapeptide binding by DppA on its afﬁnity for
heme, the highly conserved residues W442 and D445 in the
peptide-binding pocket of DppAMtb (Supplementary Fig. 8A)
were mutated to alanine. Expression experiments in E. coli did
not yield any DppAD445A protein suggesting that the mutant
protein is misfolded and degraded. By contrast, DppAW442A was
puriﬁed to apparent homogeneity with a yield of ~1 mg/l (Supplementary Fig. 8B). The DppAW442A protein was monodisperse
as determined by size exclusion chromatography (Supplementary
Fig. 8B), where it migrated as a monomer similar to wt DppA
(Supplementary Fig. 6A). Surface plasmon resonance showed that
heme bound to the DppAW442A protein but dissociated quickly
(Supplementary Fig. 8C). Screening of thousands of crystallization conditions failed to produce any crystals of DppAW442A,
in contrast to wt DppA that has a strong tendency to crystallize.
These results showed that mutation of tryptophan 442 to alanine
reduced the heme binding afﬁnity of DppA, possibly by
increasing the dynamic ﬂexibility of the DppA halves, as shown in
Fig. 5b.

in parentheses are for highest-resolution shells

opposite directions. This predicted opening of DppA halves
generates a larger pocket than seen in the crystal structure
(Richards’ solvent-accessible volume ~2583 Å3), compatible with
heme binding (Fig. 5b). Computationally docking heme against
the most open conformation predicted by normal mode analysis
yielded a physically plausible model (ΔG = −7.9 kcal/mole)
(Fig. 5c) whereby heme is in bonding distance with several DppA
residues including R179, H131, S134, E481, and L477. Speciﬁcally, in this model, R179 makes a salt bridge with one of the
propionic acid side chains, while H131 is in bonding distance
with heme iron (Fig. 5d).

Heme binding by DppA is essential for Dpp-dependent heme
uptake by Mtb. To examine the structural model in Fig. 5c, we
mutated the amino acids H131 and R179 of DppAMtb (Fig. 5d).
The yield of the DppAH131A protein in E. coli was very low, and
the puriﬁed protein failed to crystallize suggestive of improper
protein folding. By contrast, the DppAR179A protein was produced in E. coli in similar quantities as wt DppA and was puriﬁed
to apparent homogeneity with a yield of ~2 mg/l (Fig. 6a). Surface
plasmon resonance experiments (Fig. 4b) and difference
absorption spectroscopy (Fig. 6b) showed that heme-binding by
DppAR179A was almost completely abolished. The DppAR179A
protein yielded crystals of excellent quality that were used to
determine the 3D-structure to 1.25 Å resolution (Table 1). The
atomic structure of DppAR179A is identical to wt DppA with an
RMSD ~0.11 Å (Supplementary Fig. 7). The observation that
mutation of a single amino acid strongly reduced heme binding
by DppA without affecting the protein structure demonstrated
the speciﬁcity of the interaction. Collectively, these experiments
showed that arginine 179 is essential for heme binding and
identiﬁed the heme binding pocket of DppAMtb. To examine the
role of heme binding of DppA, we expressed the dpp operon
containing wt dppA and dppAR179A in the Mtb Δdpp mutant.
While the dpp operon fully restored growth, the dppAR179A gene
6

did not restore growth of the Δdpp mutant with hemin and
human hemoglobin as the sole iron sources in HdB minimal
medium (Fig. 6c, d). These results showed that under these
growth conditions, heme binding by DppA is essential for heme
utilization by Mtb.

The Dpp system is required for Mtb survival in macrophages.
In order to examine the role of the Dpp transporter in virulence
of Mtb, we constructed the unmarked Δdpp mutant ML2437 in
the virulent Mtb strain H37Rv (Supplementary Table 2). Deletion
of the dpp operon in Mtb H37Rv completely abolished growth in
Hdb minimal medium with hemin and human hemoglobin but
did not affect growth with ferric citrate as an iron source (Fig. 7a,
b). These results were identical to those obtained before for the
avirulent Mtb strains (Fig. 1) and showed that the ΔpanCD and
the ΔleuCD mutations did not have any effect on growth of the
Δdpp mutant in the avirulent Mtb strain ML2436. Thus, we used
the virulent Mtb H37Rv strain and the Δdpp mutant ML2437 to
examine whether heme acquisition contributes to Mtb survival in
macrophages. To this end, we infected differentiated THP-1 cells
with iron-depleted wt Mtb H37Rv, the siderophore-deﬁcient
ΔmbtD mutant8, and the Δdpp mutant. Survival of the ΔmbtD
and Δdpp mutants was signiﬁcantly reduced compared to wt Mtb
H37Rv 72 h after infection (Fig. 7c).
Albumin mediates heme and hemoglobin uptake by Mtb. We
made the serendipitous observation that the addition of bovine
serum albumin (BSA) to the growth medium signiﬁcantly alters
heme and hemoglobin utilization in Mtb. To examine this effect,
we repeated the growth experiments in HdB minimal medium
supplemented with 0.5% BSA, the amount in standard Middlebrook 7H9 medium for mycobacteria. Albumin did not affect
growth of the Δppe37 mutant in any manner (Fig. 2b). In the
absence of albumin, both the ppe36 and dpp mutants did not grow
with heme or hemoglobin as the sole iron sources (Fig. 8a, b)
consistent with results shown in Fig. 1 and with our previous
results15. However, albumin stimulated growth of the ppe36 and
dpp mutants in medium with heme or hemoglobin to near wildtype levels (Fig. 8a, b) indicating that Mtb bypassed the requirement for PPE36 and the Dpp transporter in the presence of
albumin. Inductively coupled plasma mass spectrometry revealed
that BSA increased the iron level in HdB medium by ﬁvefold from
13 to 64 µg/l. To assess whether the additional iron in BSA could
account for the observed improved growth of Mtb, we utilized the
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Fig. 5 Structure-based identiﬁcation of a heme-binding pocket in M. tuberculosis DppA. a Ribbon diagram of DppA overlaid with the volume of the solventaccessible pocket identiﬁed by CASTp. The pocket has a Richards’ solvent-accessible surface area of 333.4 Å2 and solvent-accessible volume ~268.4 Å3.
b Superimposition of the 10 perturbed conformations of DppA obtained by applying normal mode analysis using three lowest frequency normal modes. The
arrows show the direction of opening of the two N- and C-terminal halves. The crystallographic model of DppAwt is colored in red, while all other states are
ramped from light gray (most closed) to black (most open). c Docking model of heme (in yellow sticks) bound to the open conformation of DppA (shown
as solvent surface with N- and C-terminal halves color-coded as in a). d Zoom-view of DppA residues making contact with heme

ΔmbtD mutant ML1600 which cannot grow in medium containing
iron salts unless exogenous siderophores or hemin are added9. To
this end, we isolated mycobactins from Mtb and removed iron(III)
by extensive washing with EDTA. Addition of 10 µM deferrated
mycobactin or 10 µM ferric citrate to Hdb minimal medium did
not support growth of the ΔmbtD mutant (Fig. 8c), in contrast to
10 µM Fe(III)-mycobactin establishing that EDTA-treated MBT
does not contain signiﬁcant amounts of iron. Adding 10 µM ferric
citrate to deferrated mycobactin restored growth of the ΔmbtD
mutant, demonstrating that deferrated mycobactin is capable of
mediating iron uptake by Mtb (Fig. 8c). We observed signiﬁcant
growth of the ΔmbtD mutant in medium with 0.5% albumin and
10 µM deferrated mycobactin suggesting that mycobactin can
sequester albumin-bound iron and mediate its uptake by Mtb.
However, growth was much slower compared to mycobactin with
10 µM ferric citrate demonstrating that the iron in albumin only
partially contributes to the growth stimulation of the Mtb Δppe36
and Δdpp mutants in medium with heme and albumin (Fig. 8a, b).
Altogether, these results show that albumin mediates heme uptake
by Mtb mc26206 using an unknown mechanism independent of
the Dpp, PPE36 and PPE37 proteins.
Discussion
Heme is by far the most prevalent iron source in humans16. In
this study, we showed that the rv3666c-rv3663c operon is essential
for heme and hemoglobin utilization by Mtb in minimal medium.
These genes encode an ABC transporter which also mediates
dipeptide uptake in other bacteria33. The substrate-binding

protein DppA associated with the Dpp transporter binds heme
with high afﬁnity. We further showed that arginine 179 is
essential for heme-binding by DppA in vitro and for Dppdependent heme utilization by Mtb. These results combined with
the observations that the Mtb Δdpp mutant is more resistant to
heme toxicity and experienced iron starvation strongly indicate
that the Dpp proteins function as a heme uptake system in Mtb.
In previous studies, it was proposed that the inner membrane
RND efﬂux pumps MmpL3 and MmpL11 are involved in heme
uptake by Mtb10,34. These conclusions were primarily derived
from the observations that the Mtb mmpL11 and the M. smegmatis mmpL3 mutants grew slower in medium with heme as the
sole iron source10,34. However, the proposed functions of MmpL3
and MmpL11 in heme uptake based on these experimental
observations10,35,36 are counterintuitive. MmpL3 and MmpL11
are resistance-nodulation-cell division (RND) efﬂux pumps
involved in export of lipids molecules for biogenesis of the
mycobacterial cell wall. While MmpL3 exports trehalose monomycolate37–39, MmpL11 transports mycolic acid containing lipids
and long-chain triacylglycerolsacross out of the cytoplasm of
Mtb17,40. Importantly, RND efﬂux transporter proteins such as
the MmpL family proteins function unidirectionally and employ
sophisticated mechanisms to utilize the proton motive force to
energize export of substrates41,42. Thus, the orientation of MmpL
proteins in the membrane and the direction of proton ﬂux
through these efﬂux pumps are not compatible with the uptake of
substrates. Alternative explanations exist for the observed minor
growth defect of the mmpL3 and mmpL11 deletion mutants with
heme as the only iron source. The mmpL3 gene is essential in
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Fig. 6 Arginine 179 of DppA is essential for heme binding and utilization by M. tuberculosis. a Puriﬁcation of DppAR179A from E. coli. Lanes: (1) E. coli lysate
containing mbp6his-dppAR179A expression vector, combined fractions after Ni(II)-afﬁnity (2) and amylose afﬁnity (3), (4) puriﬁed DppAR179A post TEV
cleavage after Ni(II) recapture of MBP6His. b Difference absorption spectroscopy of DppAwt and DppAR179A. The free heme spectra were subtracted from
the heme-incubated protein spectra at protein concentrations of 10 µM. Growth of avirulent Mtb mc26206 (circles), the Δdpp mutant ML2436 (triangles),
ML2436 complemented with wt dpp operon genes (squares) and ML2436 complemented with dpp operon genes but expressing dppAR179A (diamonds).
Strains were grown in HdB minimal medium with 2.5 µM human hemoglobin (c) or 10 µM hemin (d). Medium with hemin and hemoglobin contained
20 µM of 2,2′-dipyridyl to prevent utilization of trace ferric iron. Error bars represent standard errors of mean values of biological triplicates. Please note
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both M. smegmatis and Mtb37. Thus, it is unlikely to obtain an
mmpL3 deletion mutant in the absence of secondary mutations
complicating interpretation of mutant phenotypes10,34. Deletion
of mmpL11 alters the lipid composition of the outer membrane
and impairs growth of Mtb in vitro40,43. It possible that the
MmpL3 and MmpL11 efﬂux pumps play a redundant role in
heme detoxiﬁcation by efﬂux and, thus, may have a heme-speciﬁc
utilization defect. In contrast, this study shows that Dpp system is
8

essential for heme uptake by Mtb under our experimental
conditions.
The crystal structure of DppAMtb revealed that a tetrapeptide is
bound inside the core at the N- and C-terminal domain interface
(Fig. 4c). The peptide-binding site of DppAMtb is similar to that of
other DppA proteins with two highly conserved tryptophan
(W442) and aspartate residues (D445) (Supplementary Fig. 8A).
Thus, the structural analysis of DppAMtb is consistent with the
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function of the Dpp system as a peptide importer as previously
deduced from the observation that deletion of the Dpp transporter conferred resistance to the toxic tripeptide bialaphos in
Mtb23. Since the substrate-binding proteins determine the speciﬁcity of their associated ABC transporters44, the crystal structure of the DppAMtb-tetrapeptide complex also supports the
previous conclusion that the transporter encoded by the rv3666crv3663c operon is an oligopeptide permease rather than a
dipeptide transporter23. However, the physiological role of the
tetrapeptide is unclear since DppAMtb was produced without
the signal peptide in the cytoplasm of E. coli. It is possible that the
tetrapeptide bound DppAMtb in E. coli co-translationally, concomitant with the folding of the two halves. The observation that
weakening the tetrapeptide binding to DppA with point mutations results in loss, or reduced expression in bacteria supports
the idea that the tetrapeptide also plays a structural role inside the
DppA core. The apparently tight peptide binding suggests that
the interaction of DppA with the DppB/DppC proteins might be
needed to transfer the peptide.
DppAMtb and DppA proteins in other bacteria bind heme
(Supplementary Table 4). However, DppA of E. coli45 and of Mtb,
as shown in this study, have been crystallized only with corebound peptides, while crystal structures of other periplasmic
heme-binding proteins associated with ABC-type heme importers
such as HmuT show proteins in complex with heme46,47. A
combination of computational, biochemical, genetic, and physiological approaches enabled us to identify a heme-binding site
in DppAMtb, which is located at the surface of DppAMtb and is
separate from the peptide binding site (Figs. 3d and 4 and Supplementary Fig. 9). Our experiments also showed that DppAMtb is
capable of simultaneously binding a tetrapeptide and heme since
we puriﬁed heme-bound DppAMtb (Supplementary Fig. 6), but
obtained only structures of DppAMtb with a tetrapeptide but not
with heme in different crystal forms (Fig. 4). The inhibition of
Dpp-dependent heme utilization in Mtb by tryptone-derived
peptides (Supplementary Fig. 5) might be explained by the key
role of DppA for the function of the Dpp transporter and competitive binding of tryptone-derived peptides to the heme-binding
pocket. The adaptation of the DppA substrate-binding site to
accommodate both heme and peptides might also explain the
lower heme-binding afﬁnities of DppA proteins (1.5–655 µM)
compared to dedicated periplasmic heme-binding proteins such
as PhuT and HmuT (1 to 30 nM, Supplementary Table 4). The
normal mode analysis indicated that DppA is capable of undergoing conformational changes that open the two protein halves

like a clam and enable DppA to bind heme and release it upon
binding to the Dpp importer. Since mutations of the conserved
tetrapeptide binding residues W442 and D445 destabilized the
DppA overall structure and, consequently, heme binding (Supplementary Fig. 8), we propose that the inner tetrapeptide plays a
structural role, holding the two halves of DppA together and
forming a distal heme-binding pocket, designed for reversible and
transient binding of heme.
Our ﬁndings suggest a model of heme and hemoglobin utilization by Mtb (Fig. 9) wherein the surface-exposed, hemebinding membrane proteins PPE36/PE22 and PPE62 are required
for both heme and hemoglobin utilization indicating that both
pathways converge at the cell surface of Mtb. This implies that
heme is stripped from hemoglobin by an unknown mechanism
and then transferred to PPE36/PE22 and PPE62. Under our
experimental conditions, deletion of PPE62 only partially impairs
heme utilization, whereas deletion of PPE36 completely abolished
growth of Mtb with heme indicating that it performs an essential
function in contrast to PPE62 (ref. 15). After crossing the outer
membrane, heme is bound by Rv0265c. The growth defect of the
Mtb Δrv0265c mutant in heme medium was signiﬁcant but not
severe, indicating that functional homologs of Rv0265c exist in
Mtb15. Within the periplasm heme is then bound to DppA which
possibly transfers heme to the Dpp transporter consisting of the
DppB/DppC permease and the DppD ATPase. The function of
the substrate-binding protein DppA is essential for heme utilization by Mtb under the experimental conditions in this study.
Since we cannot exclude the possibility that DppA may transfer
heme to a non-cognate permease, the role of the DppBC permease in heme uptake by Mtb is unclear. The heme uptake
mechanism dependent on the Mtb proteins PPE36 and the Dpp
transporter in this model (Fig. 9) is different from other pathogenic heme-utilizing bacteria which employ homologs of the
Yersinia enterocolitica HemTUV permease14,48. Our study also
revealed an alternative pathway for heme uptake based on albumin, which is independent of the Dpp, PPE36, and PPE37 proteins (Fig. 9). Albumin-mediated heme utilization was also
observed in H. inﬂuenzae strains49. Human serum albumin is the
most abundant protein in the blood50 and speciﬁcally binds heme
with high afﬁnity51–53. BSA is highly similar to human serum
albumin (76% homology), is used in mycobacterial media at a
concentration of 75 μM and binds hemin with an afﬁnity of 104
1/M54. Thus, at a hemin concentration of 10 μM, as in our
experiments, practically all hemin is bound to BSA and not to the
lower afﬁnity PPE36 surface protein15. The much higher afﬁnity
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Fig. 9 Model of heme acquisition by M. tuberculosis. PPE36/PE22 and PPE62
are cell surface-accessible proteins of Mtb that bind heme (red octagon) and
are anchored in the outer membrane (OM)15. After uptake across the OM,
heme is transferred to the periplasmic lipoprotein DppA, possibly with the
help of the periplasmic heme-binding protein Rv0265c. DppA probably
delivers heme to the DppBCD transporter for uptake across the inner
membrane (IM) as shown for other substrate-binding proteins of ABC
transporters75,76. PPE37, which was recently shown to be essential for heme
utilization in Mtb Erdman, is not depicted since its localization is unknown.
Cytoplasmic heme is degraded to mycobilin by the oxygenase MhuD thereby
releasing iron (black dot). Heme is degraded in the cytoplasm by the
oxygenase MhuD to release iron. MmpL3 and MmpL11, which may be
involved in heme efﬂux, are not depicted since it has not been experimentally
validated. The fact that PPE36/PE22, PPE62, and the Dpp transporter are
required for heme and hemoglobin utilization by Mtb indicates that these
pathways converge at the cell surface of Mtb. Our study indicates that there
is an alternate heme uptake pathway mediated by albumin, whose
components are not known. However, the mechanism by which heme is
released from hemoglobin is unknown. Figure adapted from ref. 15

of human serum albumin for hemin with a binding constant of
10 nM−1 51 indicates that, during infection of humans, Mtb
predominantly uses the albumin pathway for heme uptake when
blood is available, e.g., in destroyed lung tissue with extracellular
Mtb55. In the absence of blood, e.g., when Mtb resides inside cells,
the PPE36/DppA pathway is required for heme uptake.
Obviously, further experiments are necessary to examine the
mechanism of albumin-mediated heme uptake by Mtb. After
heme enters the cytoplasm, it is cleaved by the heme oxygenase
MhuD releasing iron36. Potential heme efﬂux to reduce the
toxicity of excess heme as shown in other bacteria56 and as
suggested previously for Mtb15 is not depicted in this model since
it has not been experimentally examined yet.
Recently, it has been shown that PPE37 is essential for heme
utilization in the Mtb Erdman strain, but PPE36 is not24. We
showed in this study that PPE36 is essential for heme utilization
in the H37Rv-derived avirulent Mtb strain mc26206, but PPE37 is
not. It is possible that genetic variations could result in different
10

requirements for heme utilization between the two Mtb laboratory strains (H37Rv versus Erdman). For example, in our
experiments, deletion of ppe37 stimulated growth of Mtb
mc26206 under all conditions tested (Fig. 2). An alternative
explanation for the different requirements for PPE36 and PPE37
in the Erdman and H37Rv strains might be the profound effect of
albumin on heme utilization by Mtb as observed in our study.
While the experiments with the Erdman strain were done in the
presence of albumin24, our previous15 and current experiments
with the H37Rv-derived strains were done in medium without
albumin. Thus, it is possible that PPE37 is required for uptake of
the albumin–hemin complex.
The importance of the dpp operon for growth and/or survival
of Mtb in vivo was shown previously using an Mtb deletion
mutant lacking the rv3665c-rv3663c genes. This mutant had a
signiﬁcantly reduced bacterial burden during the chronic phase of
the infection in mice compared to wt Mtb23. We observed that
replication of both the heme-deﬁcient Δdpp and the siderophoredeﬁcient ΔmbtD Mtb mutants was impaired in human THP-1
macrophages compared to wt Mtb H37Rv (Fig. 7). Several other
genes involved in iron metabolism of Mtb are also required for
full virulence of Mtb in mice7,12,57. The conclusion that iron
availability is important for Mtb during infection is also supported by the observation that high concentrations of transferrin,
haptoglobin, and hemopexin are present in the necrotic centers of
lung granulomas, the primary sites of infection in human TB
patients5. These proteins sequester ferric ions, hemoglobin, and
heme, respectively, and create an iron-deprived environment.
Importantly, iron starvation triggers the transition of Mtb to a
persistent, drug-resistant state, while iron availability restarts
replication of persistent Mtb5. These ﬁndings collectively indicate
that iron uptake is important for Mtb virulence. Consistent with
this conclusion is the emerging complexity of iron acquisition
mechanisms in Mtb. Mtb not only produces two classes of siderophores with different biochemical properties, the hydrophobic
mycobactins and the more water-soluble carboxymycobactins58,
but it also employs at least two different mechanisms of iron
utilization from heme and hemoglobin as shown in this study and
other studies15,24. However, it is unclear whether iron acquisition
from heme and from iron-siderophore complexes are redundant
mechanisms or whether these mechanisms are separately
required at different stages of the infection. To evaluate the
contribution of these pathways to virulence of Mtb is not trivial
because gene deletions in the large mycobactin biosynthesis
operon are known to have pleiotropic effects59. A similar complication also exists for the Dpp transporter which modulates the
transcription of hundreds of genes and alters the lipid composition on the cell surface of Mtb23. Further, the dual function of the
Dpp transporter makes it difﬁcult to determine whether the
in vivo roles of Dpp are due to the lack of heme and/or peptide
uptake. In conclusion, the iron-acquisition mechanisms of Mtb
are capable of capturing iron from different sources. Their roles
in virulence are likely determined by the varying environmental
niches of Mtb during infection.
Methods
Bacterial strains, media, and growth conditions. Virulent Mtb H37Rv and its
derivative strains were grown in Middlebrook liquid 7H9 or solid 7H10 medium
supplemented with 10% OADC (8.5 g/l NaCl, 20 g/l dextrose, 50 g/l bovine albumin fraction V, 0.03 g/l catalase, 0.6 ml/l oleic acid). Avirulent Mtb mc26206 and its
derivative strains were grown in Middlebrook liquid 7H9 or solid 7H10 medium
supplemented with 0.5% glycerol, 10% ADS (8.5 g/l NaCl, 20 g/l dextrose, 50 g/l
bovine albumin fraction V), 0.2% casamino acids, 24 μg/ml pantothenate, and
50 µg/ml L-leucine. Escherichia coli DH5α was grown in either LB medium containing appropriate antibiotics at 37 °C with shaking at 200 r.p.m. The following
antibiotics were used when required: ampicillin (Amp) at 100 μg/ml for E. coli,
kanamycin (Kan) at 30 μg/ml for mycobacteria, and 50 μg/ml for E. coli, and
hygromycin (Hyg) at 200 μg/ml for E. coli and 50 μg/ml for mycobacteria.
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Targeted gene deletion in M. tuberculosis. Gene deletion was performed as
previously described15. To construct the dpp and ppe37 mutants, upstream (U) and
downstream (D) sequences were ampliﬁed using corresponding primer pairs UF/
SpeI-UR/SwaI and DF/PacI-DR/NsiI (Supplementary Table 4), respectively, and
cloned into pML2424 to construct pML3753 (dpp deletion vector) and pML3769
(ppe37 deletion vector) (Supplementary Table 3). A promoter was inserted
upstream of rv3662c to prevent polar effects from deletion of the dpp genes. The
deletion vectors were then transformed into avirulent Mtb mc26206 and virulent
Mtb H37Rv. Transformants were selected at 37 °C on 7H10 Hyg and visually
validated through the presence of both GFP and RFP ﬂuorescence. Liquid culture
of transformant was then plated on 7H10 Hyg containing 2% sucrose at 40 °C for
selection of double crossovers. Putative double crossovers were visually analyzed
for the presence of only GFP and gene deletion was validated by PCR. For excision
of the loxP-ﬂanked gfp2+m-hyg cassette, pML2714 expressing Cre recombinase was
transformed into marked mutants and unmarked mutants were selected on 7H10
Kan at 37 °C. Putative unmarked mutants were ﬁrst visually validated through the
absence of GFP ﬂuorescence and then through PCR (Supplementary Figs. 1 and 3)
(primers, Supplementary Table 4) and loss of growth on hygromycin. The
unmarked avirulent and virulent dpp mutants were designated as ML2436 and
ML2437, respectively, and the unmarked avirulent ppe37 mutant was designated as
ML2451 (Supplementary Table 2).
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allow consistent growth for all strains. All plates were incubated at 37 °C with
shaking for ten days and growth was determined using Alamar Blue assay.

Construction of expression vectors for mycobacteria. The dpp (rv3666crv3663c) and opp (rv1283c-rv1280c) operons were ampliﬁed using corresponding
primers, 016Clone/F and 016Clone/R (Supplementary Table 4), and cloned into
pMN016 to construct pML3757 and pML3758, respectively (Supplementary
Table 3). The wild-type copy of dppA in pML3757 was replaced with the mutated
dppAR179A gene to construct pML3759 (Supplementary Table 3).

RNA extraction and quantitative real-time PCR. Strains were ﬁrst grown to log
phase in 7H9 medium, then washed in sterile PBS with 0.02% Tyloxapol and irondepleted for 3–4 generations in iron-free 7H9 medium. Strains were then inoculated at OD600 of 1.0 into 60 ml HdB minimal medium containing either 10 µM
hemin or 10 µM ammonium ferric citrate as the sole iron source and incubated for
48 h at 37 °C with shaking at 100 r.p.m. Cells were harvested by centrifugation at
5000g for 5 min at 4 °C and resuspended by vortexing in 1 ml Trizol. Cells were
lysed with beads at 20 s intervals for 1 min with cooling on ice in between bead
beading steps. Beads were precipitated by centrifugation and the Trizol solution
was added to 0.3 ml of phenol/chloroform/isoamyl alcohol. Tubes were inverted
repeatedly at 30 s intervals for 2 min and then centrifuged at 16,000g for 5 min at
4 °C. The aqueous layer was removed to a separate tube containing 0.8 ml of a 1:1
mixture of isopropanol and 3 M sodium acetate. Tubes were inverted several times
and nucleic acids were allowed to precipitate overnight at −20 °C. Tubes were then
centrifuged at 16,000g for 10 min at 4 °C and the nucleic acid pellet was washed
twice with ice-cold 70% ethanol. The pellet was air dried and resuspended in 100 µl
of DEPC-water. On column DNA digestion and RNA isolation were then performed using the Qiagen RNeasy Kit as per the manufacturer’s protocol. cDNA
synthesis was performed using the Bio-Rad iScript cDNA Synthesis Kit as per the
manufacturer’s protocol. qRT-PCR cycling conditions for relative quantitation of
gene expression was performed using Bio-Rad iQ SYBR Green in a CFX96 RealTime cycler (Bio-Rad). Cycle threshold (Ct) data were normalized to rrs (Mtb 16S
rRNA gene) and normalized Ct values (ΔCt) were transformed to arbitrary gene
expression units using the 2−ΔCt/10−6 method as described by Livak and
Schmittgen61.

Growth experiments for determining iron utilization. Strains were ﬁrst grown in
7H9 medium, then washed in sterile PBS (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4) with 0.02% Tyloxapol and iron-depleted for 3–4
generations in iron-free 7H9 medium. Strains were then inoculated into HdB
minimal medium60 containing either 10 µM hemin or 2.5 µM human hemoglobin
or 10 µM ammonium ferric citrate as the sole iron source. BSA was added to a ﬁnal
concentration of 0.5% w/v into HdB minimal medium for albumin growth
experiments. To prevent growth from iron traces 20 µM of the iron chelator 2,2dipyridyl (DIP) was added to the medium containing heme or human hemoglobin.

Construction of expression vectors for E. coli. The dppA gene, excluding the ﬁrst
75 base pairs, was ampliﬁed using corresponding primers, 1970Clone/F and
1970Clone/R (Supplementary Table 4), and cloned into pML1970 to construct
pML3780 (Supplementary Table 3). Mutated DppAH131A, DppAR179A, DppAW442A,
and DppAD445A were constructed using mutations primers (Supplementary
Table 4) and subsequently validated by Sanger sequencing. The DppA mutants
H131A, R179A, W442A, and D445A were cloned into pML1970 to construct
pML3781, pML3783, pML3786, and pML3790, respectively (Supplementary
Table 3).

Production of deferrated mycobactins. Fe(III)-mycobactin (100 mg) was ﬁrst
incubated in the presence of 50 mM EDTA (pH 4.0) at 37 °C for 18 h. EDTA was
precipitated by centrifugation and supernatant was collected in a fresh tube.
Siderophores were extracted twice by adding an equal volume of chloroform to the
supernatant and collecting the top organic layer containing the deferrated mycobactin. Chloroform was removed through evaporation and the deferrated mycobactin residue was suspended in a 1:1 mixture of ethanol and 50 mM KH2PO4
buffer (pH 7.0).

Protein puriﬁcation. Transformants of pML3780, pML3781, pML3783, and
pML3786 in E. coli BL21 (DE3) were selected on LB Amp agar plates. All proteins
were puriﬁed using the same method. Brieﬂy, starter cultures of strains were
inoculated into 500 ml of fresh LB medium with ampicillin and grown to an OD600
of 0.3. Gene expression was induced with 1 mM IPTG at 18 °C for 24–30 h. After
induction of gene expression E. coli, cells were harvested by centrifugation and
lysed by sonication in ice-cold base buffer (20 mM Tris, 300 mM NaCl, 15% glycerol, 1 mM PMSF, pH 7.4). The cell lysate was clariﬁed by centrifugation and the
supernatant was loaded on to activated nickel resin and bound overnight at 4 °C
with shaking. Protein loaded resin was washed three times with wash buffer (base
buffer with 25 mM imidazole) and target protein was eluted with elution buffer
(base buffer with 250 mM imidazole). Eluted protein was then loaded on to activated amylose resin followed by three washes with base buffer and then eluted with
base buffer containing 20 mM maltose. The fusion protein was then incubated with
puriﬁed TEV6His protease (self-made) at room temperature for 24–48 h or until all
fusion protein was cleaved. Following cleavage, the protein solution was then
loaded on activated nickel resin, where the MBP6His tag and TEV6His were captured
on the resin and DppAMtb was collected in the ﬂow through. Cleaved DppA was
further puriﬁed using a Superdex 75 (GE Healthcare Life Sciences) size exclusion
chromatography column. The ﬁnal puriﬁcation yield for DppAwt, DppAR179A, and
DppAW442A were similar (~2 mg/l) while DppAH131A was recovered in small
quantities (~0.2 mg/l). All DppA variants were concentrated by ultraﬁltration using
a Vivaspin20 10 kDa concentrator (Sartorius).

Role of opp genes and peptides in heme utilization. Strains were ﬁrst grown to
log phase in 7H9 medium, then washed in sterile PBS with 0.02% Tyloxapol and
iron-depleted for 3–4 generations in iron-free 7H9 medium. In 96-well plates,
washed Mtb cells were inoculated at an OD600 of 0.05 into HdB minimal medium60
containing either 10 µM hemin or 2.5 µM human hemoglobin or 10 µM ammonium ferric citrate as the sole iron source. For peptide competition assays all media
also contained a mixture of tryptone and yeast extract at 1% w/v ﬁnal concentration. All heme and hemoglobin media contained 20 µM of the iron chelator
2,2-dipyridyl (DIP) to prevent utilization of trace iron. All plates were incubated at
37 °C with shaking for ten days and growth was determined using Alamar Blue
assay as described30.
Ethidium bromide accumulation assay. All strains were ﬁrst grown to log phase
in 60 ml of 7H9 medium. Cells were ﬁltered through a 5.0 µM ﬁlter to obtain a
single-cell suspension and allowed to grow for another 24 h to relieve any membrane stress induced from ﬁltration. Cells were then harvested by low-speed centrifugation at 1500g for 10 min and resuspended to a ﬁnal OD600 of 1.0 in uptake
buffer (76 mM (NH4)2SO4, 0.5 M KH2PO4, 1 mM MgSO4, 0.4 % glucose and 0.05%
Tween-80). For both strains, 100 µl of cells were added in triplicate in a 96-well
plate and ethidium bromide was then added to a ﬁnal concentration of 20 µM.
Fluorescence was measured by excitation at 530 nm and emission at 590 nm at
2 min intervals for 60 min.
Heme toxicity assay. Wild-type H37Rv and mutant derivative strains were ﬁrst
grown to log phase in 7H9 medium, then washed in sterile PBS with 0.02%
Tyloxapol and iron-depleted for 3–4 generations in iron-free 7H9 medium. In 96well plates, washed Mtb cells for all strains were inoculated at an OD600 of 0.05 into
HdB minimal medium containing 1 µM ammonium ferric citrate and increasing
concentrations of hemin. Ammonium ferric citrate was included in the medium to

Crystallization and structure determination. DppAwt and the mutant
DppAR179A were crystallized using the vapor diffusion hanging drop method by
mixing 2 µl of puriﬁed protein (typically concentrated at 15–18 mg/ml) with an
equal volume of crystallization solution containing 0.2 M Sodium malonate pH 6.0
and 22% (w/v) PEG3350. In contrast, DppAH131A failed to crystallize. DppA
crystals were harvested in nylon cryo-loops, cryo-protected with 27% ethylene
glycol and ﬂash-frozen in liquid nitrogen. Diffraction data for DppAwt were collected at beamline 9-2 at a wavelength of 0.97 Å, at Stanford Synchrotron Radiation
Lightsource (SSRL), on a Dectris Pilatus 6M detector. Crystals of DppAR179A were
diffracted at Cornell High Energy Synchrotron Source (CHESS) F1 beamline station at a wavelength of 0.98 Å, on a Dectris Pilatus 6M detector. All steps of data
indexing, integration, and reduction were carried out using HKL2000 (ref. 62) and
CCP4 programs63. The structure was solved by molecular replacement (MR) using
the periplasmic oligopeptide-binding protein from Salmonella typhimurium (PDB
1B7H) (~24% sequence identical to DppAMtb) as a search model, as implemented
in PHASER64. The initial MR solution was reﬁned and partially rebuilt using
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ARP/wARP65, which built approximately 50% of DppAwt residues. This initial
model (Rfree ~37%) was then entirely built by alternating cycles of the automated
model building with phenix.autobuild66 and manual rebuilding using COOT67.
The completed model was then subjected to positional and anisotropic B-factor
reﬁnement in Phenix68 and ﬁnal re-reﬁnement using PDB_redo69, which yielded
the best Rwork/Rfree and stereochemistry. The ﬁnal models were reﬁned to an Rwork/
Rfree of 12.8/16.5% (DppAwt) and 16.3/18.8% (DppAR179A) using all diffraction data
between 50–1.27 Å and 15–1.25 Å, respectively. The ﬁnal DppAwt model has 97.3%
of residues in the most favored regions and 2.7% in allowed regions of the
Ramachandran plot and no outliers in disallowed regions. DppAR179A has 97.1% of
residues in the most favored regions and 2.9% in allowed regions of the Ramachandran plot and no outliers in disallowed regions. Final model validation was
done using MolProbity70. Crystallographic data collection and reﬁnement statistics
are shown in Table 1.
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